Affiliated with a Castle Connolly Top Hospital
Who is Dr. Neal, Medical Oncologist in Stanford, CA?
Dr. Joel Neal, MD, PHD is a Medical Oncologist, who primarily practices in Stanford, CA with 2 additional practice locations. He is board certified. Dr. Neal graduated from Feinberg School of Medicine - Northwestern University and completed his residency at Beth Israel Deaconess Medical Center. Dr. Neal is fluent in English, and is currently seeing new patients. Dr. Neal’s practice accepts Kaiser Permanente, Medicaid, Medicare, Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Neal’s office at (650) 498-6000.
What are Areas of Expertise for Dr. Neal?
Dr. Joel Neal, MD, PHD is a highly-rated, board-certified Medical Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Neal empowers patients to confidently navigate their health journey, specializing in Lung Cancer, Mesothelioma, Thoracic Cancers, Thymoma and Thymic Cancer, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Neal is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Neal go to medical school and complete their residency?
Fellowship: Dana-Farber Cancer Institute MA | Dana Farber Cancer Institute
Residency: Beth Israel Deaconess Medical Center
Medical School: Feinberg School of Medicine - Northwestern University
Is Dr. Neal board certified as a Medical Oncologist?
Yes, Dr. Joel Neal, MD, PHD is board certified by the American Board of Internal Medicine since 2010, American Board of Internal Medicine since 2007
What languages does Dr. Neal speak?
Dr. Neal and their clinical team can communicate with patients in the following languages:
English
What conditions does a Medical Oncologist like Dr. Neal typically treat?
As a Medical Oncologist, Dr. Neal diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Neal. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Lung Cancer
- Right upper lobe lung cancer
- Bronchial cancer
- Malignant neoplasm of lung
- Pulmonary cancer
- Right lung cancer
- Left Lung Cancer
- Upper Lobe Lung Cancer
- Bronchial Cancer
- Left lower lobe lung cancer
ICD-10 Codes:
- C3411: Malignant neoplasm of upper lobe, right bronchus or lung
- C3490: Malignant neoplasm of unspecified part of unspecified bronchus or lung
- C3491: Malignant neoplasm of unspecified part of right bronchus or lung
- C3412: Malignant neoplasm of upper lobe, left bronchus or lung
- C3432: Malignant neoplasm of lower lobe, left bronchus or lung
What procedures does a Medical Oncologist like Dr. Neal typically perform?
As a Medical Oncologist, Dr. Neal performs a variety of medical procedures. This procedure information is derived from anonymized insurance claims and highlights the medical procedures most commonly performed by Dr. Neal. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Blood Transfusion
- Blood Transfusion and Donation
- Blood product transfusion
- Red blood cell transfusion
- Plasma transfusion
CPT Codes:
- 36430: Transfusion, blood or blood components
Also known as:
- Swallowing Therapy
- Dysphagia Treatment
- Feeding Therapy
- Oral Function Therapy
CPT Codes:
- 92526: Treatment of swallowing dysfunction and/or oral function for feeding
Also known as:
- Removal of Benign Skin Lesions
- Benign Skin Growth Destruction
- Skin Lesion Excision
- Cryosurgery for Skin Lesions
- Electrosurgery for Skin Lesions
CPT Codes:
- 17110: Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions
Does Dr. Neal accept my insurance?
Dr. Neal accepts most major insurance plans. Important: Please call our office at (650) 498-6000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Neal accept in Stanford, CA?
Dr. Neal in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Medicaid
Medicare
Santa Cruz County
State of California
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Neal's office located?
Recognitions
Publications
A Patient With Aplastic Lymphoma Kise-Positive Non
, 2013
A Case Series of NSCLC Patients with Different Molecular Characteristics
, 2013
Targeting fibroblast growth factor receptor
, 2012
A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non-Small-Cell Lung Cancer
, 2012
Complex Role of Histone Deacetylase Inhibitors in the Treatment of Non-Small-Cell Lung Cancer
, 2012
Ipilimumab in Combition With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB
, 2012
Current Magement of Small Cell Lung Cancer
, 2011
Targeting FGFR, Ephrins, Mer, MET, and PDGFR-alpha in Non-small Cell Lung Cancer
, 2011
The SATURN trial: the value of maintence erlotinib in patients with non-small-cell lung cancer
, 2010
Cetuximab monotherapy in patients with advanced non
, 2010
Targeted therapies: optimal first-line therapy for NSCLC with EGFR mutations.
, 2010
First-line use of EGFR tyrosine kise inhibitors in patients with NSCLC containing EGFR mutations.
, 2010
Induction of FucT-VII by the Ras/MAP kise cascade in Jurkat T cells
, 2003
A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts
, 2003
Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1 cells
, 2002
Glycogen synthase kise-3 inhibits the D binding activity of NFATc
, 2001
REGULATION OF THE GLUCOSE-H+ SYMPORTER BY METABOLITE
, 1994
A Case Series of Lengthy Progression-Free Survival With Pemetrexed
, 2013
A Patient With Anaplastic Lymphoma Kinase-Positive Non
, 2013
A Case Series of NSCLC Patients with Different Molecular Characteristics
, 2013
Aflibercept in lung cancer
, 2013
Targeting fibroblast growth factor receptor
, 2012
A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non-Small-Cell Lung Cancer
, 2012
Complex Role of Histone Deacetylase Inhibitors in the Treatment of Non-Small-Cell Lung Cancer
, 2012
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB
, 2012
First-line treatment of EGFR-mutant non-small-cell lung cancer
, 2012
Current Management of Small Cell Lung Cancer
, 2011
Targeting FGFR, Ephrins, Mer, MET, and PDGFR-alpha in Non-small Cell Lung Cancer
, 2011
One Allele's Loss Is Another's Gain: Alterations of NKX2-8 in Non-Small Cell Lung Cancer
, 2011
The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
, 2010
Cetuximab monotherapy in patients with advanced non
, 2010
AMG-386, a selective angiopoietin-1/-2-neutralizing peptibody for the potential treatment of cancer
, 2010
Exciting New Targets in Lung Cancer Therapy: ALK, IGF-1R, HDAC, and Hh
, 2010
Targeted therapies: optimal first-line therapy for NSCLC with EGFR mutations.
, 2010
First-line use of EGFR tyrosine kinase inhibitors in patients with NSCLC containing EGFR mutations.
, 2010
Induction of FucT-VII by the Ras/MAP kinase cascade in Jurkat T cells
, 2003
A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts
, 2003
Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1 cells
, 2002
Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc
, 2001
REGULATION OF THE GLUCOSE-H+ SYMPORTER BY METABOLITE
, 1994
What is Dr. Neal's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Neal's National Provider Identifier (NPI) number is 1790858942.
What common questions do patients ask about Dr. Neal?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Neal
What is Dr. Joel Neal's specialty?
Dr. Neal is a Medical Oncologist near Stanford, CA.
What does a Medical Oncologist do?
An internist specializing in the diagnosis and treatment of various cancers and both benign and malignant tumors. This specialist determines and administers therapy for malignancies and collaborates with surgeons and radiation oncologists on additional cancer treatment options.
Is this Dr. Joel Neal affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Neal is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Medical Oncologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Medical Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Joel Neal accepting new patients in Stanford, CA?
Yes, Dr. Joel Neal is accepting new patients at this time.
Does Dr. Joel Neal offer online booking?
Please contact Dr. Neal's office at (650) 498-6000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Joel Neal?
Please contact Dr. Neal's office at (650) 498-6000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Joel Neal have?
Dr. Joel Neal is certified by the American Board of Internal Medicine.
Other Medical Oncologist Near Stanford, CA
Medical Oncologist
Accepting patientsMedical Oncologist
Accepting patientsMedical Oncologist
Accepting patients